TEAM

CEO

• 25 years experience.

• 11 years in Biotech (Neurocrine), GPCR, metabolic, neural and cardiovascular

• Over 20 years of experience in PhD/Post-doc/Lab Head positions studying a variety of fields, including Crohn's disease, cancer, schizophrenia, and human-specific neural sophistication

• Research spanning a range of areas, such as epigenetics, bioinformatics, and RNA/DNA editing, with a common goal of pushing boundaries for practical therapeutic translation

Scientific Advisor

• Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and its associated diseases

• He is the Director of the Centre for Healthy Ageing at National University Singapore and a Distinguished Professor in Biochemistry and Physiology

• He has published over 200 manuscripts in prestigious journals, and his own research has led to the discovery of Sirtuins and the mTOR pathway as key regulators of aging

• He has held leadership positions at the Buck Institute for Research on Aging and is currently involved in several biotech companies, serving in consulting and Board capacities

Executive Chairman

• Experienced BioTech entrepreneur and executive

• Developed businesses in stem cell extracellular vesicle therapies for orphan drug conditions in premature neonates, neurological cellular regeneration

• He has worked on a medical device to reverse cardiorenal failure

• He is a US lawyer and UK solicitor

COO

• Assists in operational capacity to bring companies from early stage to IPO

• She guided the public listing of Genflow Biosciences, and guided the growth of the deep tech startup FLOX from pre-seed to over 25 employees during the COVID pandemic 

• She studied for a Double Major in Computer Science and International Development at McGill University